June 10, 2022

The Top Line

Jun 10 2022 • 34 mins


Another ASCO and more CAR-T data. Arcellx presented early results on its multiple myeloma therapy at last weekend’s ASCO annual meeting, and we dig into what it would take to stand up to J&J's Carvykti. But that’s not all. People were on their feet for the Enhertu breast cancer drug and its unheard-of results. We’ve got a lot to share about ASCO. Also under discussion is Fierce's special report on the rising stars in the medtech and healthcare fields and what they have in common. Lastly, we finally have boots-on-the-ground at an industry conference. Our reporter headed out to the first in-person ASCO since the pandemic started. She planned to learn about new data releases and discoveries, and also found out something surprising about herself.

<>

To learn more about the topics in this episode:

The Top Line is produced by senior multimedia producer Teresa Carey with editor-in-chief Tracy Staton, managing editor Querida Anderson and senior editors Annalee Armstrong, Ben Adams, Conor Hale and Eric Sagonowsky. The sound engineer is Caleb Hodgson. The stories are by all our “Fierce” journalists.

See omnystudio.com/listener for privacy information.